Norman Fields Gottscho Capital Management LLC Cuts Position in Agilent Technologies, Inc. $A

Norman Fields Gottscho Capital Management LLC trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 1.8% during the second quarter, HoldingsChannel.com reports. The firm owned 16,345 shares of the medical research company’s stock after selling 300 shares during the quarter. Agilent Technologies comprises 0.6% of Norman Fields Gottscho Capital Management LLC’s investment portfolio, making the stock its 19th biggest position. Norman Fields Gottscho Capital Management LLC’s holdings in Agilent Technologies were worth $1,929,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Dudley & Shanley Inc. raised its holdings in shares of Agilent Technologies by 12.2% in the 2nd quarter. Dudley & Shanley Inc. now owns 55,200 shares of the medical research company’s stock worth $6,514,000 after purchasing an additional 6,000 shares during the period. Czech National Bank raised its holdings in shares of Agilent Technologies by 6.4% during the 2nd quarter. Czech National Bank now owns 69,689 shares of the medical research company’s stock valued at $8,224,000 after buying an additional 4,163 shares during the period. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Agilent Technologies by 32.7% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,777 shares of the medical research company’s stock valued at $210,000 after buying an additional 438 shares during the period. S.E.E.D. Planning Group LLC raised its holdings in shares of Agilent Technologies by 13.3% during the 2nd quarter. S.E.E.D. Planning Group LLC now owns 103,814 shares of the medical research company’s stock valued at $12,251,000 after buying an additional 12,181 shares during the period. Finally, Parallel Advisors LLC raised its holdings in shares of Agilent Technologies by 18.1% during the 2nd quarter. Parallel Advisors LLC now owns 6,180 shares of the medical research company’s stock valued at $729,000 after buying an additional 948 shares during the period. 87.41% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the business’s stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares in the company, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.26% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on A shares. Robert W. Baird raised their target price on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday, August 28th. Evercore ISI dropped their target price on Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating on the stock in a report on Thursday, August 28th. JPMorgan Chase & Co. dropped their target price on Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 29th. TD Cowen raised their target price on Agilent Technologies to $150.00 and gave the company a “buy” rating in a report on Thursday, May 29th. Finally, UBS Group dropped their target price on Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a report on Thursday, May 29th. Six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $140.08.

Agilent Technologies Price Performance

Shares of A opened at $125.68 on Tuesday. The firm has a market cap of $35.63 billion, a price-to-earnings ratio of 29.50, a PEG ratio of 3.83 and a beta of 1.24. The stock has a 50 day moving average of $119.89 and a 200-day moving average of $115.77. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the firm earned $1.32 EPS. The business’s revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.